Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Pharmaceutical News
Sinobiopharma signs cooperative pact to develop Eplerenone2010-08-13
New Potassium Clavulanate project started construction2010-08-12
Zhongya Pharma to build Erythromycin thiocyanate project2010-08-12
NHU to stop VE production temporarily2010-08-11
Sinobiopharma got clinical approval of Eplerenone2010-08-11
China-made pill passed Phase II clinical trials in USA2010-08-10
United Laboratories increases prices of Amoxicillin and 6-APA2010-08-09
4-methylMethcathinon controlled as psychotropic drug in China2010-08-06
Hengyuan to expand Montelukast sodium capacity2010-08-05
Xinchang's Vancomycin project awarded an honorary title2010-08-04
Charles River terminates acquisition pact with Wuxi Pharmatech2010-08-03
Hisun plans raise 1.36 bln yuan to build production unit2010-08-03
First nationwide study on TCM to release in Nov2010-08-03
Charles River Labs calls off WuXi Pharmatech buy2010-08-02
Second Pharma seeks registration of Valsartan capsules in USA2010-07-30
Stellar got patent warrant from Chinese Patent Office2010-07-30
New APIs production base started construction in Hubei2010-07-29
Qilu pharma is building two subsidiaries in Linyi2010-07-29
SFDA approves production of Ciclopirox Olamine vaginal suppositories2010-07-28
Leo Pharma to recall all batches of Sodium Fusidate in China2010-07-28
Merck collaborates with Sinopharm to boost China presence2010-07-28
Boehringer Ingelheim to expand stuff in China2010-07-27
Huifeng Biopharma got Spanishi order2010-07-27
Huachi Medical becomes big supplier of natural Saponin2010-07-26
A big unit of APIs under construction in Tianjin Jinghai2010-07-26
One more project of Nicotinic started construction2010-07-23
Shengxue Dacheng got COS certificate for Streptomycin Sulfate2010-07-23
Zhongheng to build Erythromycin project in Wuzhou2010-07-22
A Nicotinic acid project to build in Mianyang2010-07-22
Capacity of Vitamin C project in Heihe is 10000 ton finally2010-07-21
Novartis hypertension drug gets Chinese approval2010-07-21
Sanofi-Aventis to increase insulins output in China2010-07-20
共4532个 页次:110/142页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463